Aclaris Therapeutics, Inc. Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • Aclaris Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $14.8M, a 63.7% decline year-over-year.
  • Aclaris Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $73.4M, a 49% decline year-over-year.
  • Aclaris Therapeutics, Inc. annual Costs and Expenses for 2023 was $129M, a 7.53% increase from 2022.
  • Aclaris Therapeutics, Inc. annual Costs and Expenses for 2022 was $120M, a 24% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Costs and Expenses for 2021 was $96.5M, a 68.1% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $129M +$9M +7.53% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $120M +$23.1M +24% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $96.5M +$39.1M +68.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $57.4M -$57.9M -50.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $115M +$24.4M +26.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $90.9M +$34.9M +62.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $56M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.